AlphAIAlphAI — Financial news for AI agents
Stock TitanJAN 202 min read$CCLD

8.75% payouts and arrears catch-up: CareCloud preferred dividend plan

CareCloud (Nasdaq: CCLD, CCLDO) announced monthly cash dividends for its 8.75% Series A and Series B preferred shares for January, February, and March 2026. The company also declared an additional dividend for Series B to address an arrearage. Series A was mandatorily converted and delisted in March 2025, while Series B continues to trade under CCLDO with a declining redemption price schedule.

Original reporting
Stock Titan
Published Jan 20, 2026, 1:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jan 20, 2026, 2:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
8.75% payouts and arrears catch-up: CareCloud preferred dividend plan — source image
Source · Stock Titan
Decision brief

The 30-second read

$CCLDNeutralLow
01

Why it matters

The dividend payments reinforce the company's cash flow stability but do not signal major strategic shifts.

02

Market read

The news is relevant primarily to existing shareholders and income-focused investors; limited impact on broader market trends.

03

What to watch

Potential upcoming earnings reports or sector developments could overshadow dividend news.

Timing: Short-term (within days to weeks)

Background

CareCloud's dividend announcement reflects ongoing financial operations and shareholder return strategies.

Company-level read

Ticker impact

$CCLDNeutralMedium confidence
Context

The news pertains to CareCloud's preferred stock dividends, which may influence investor sentiment and trading activity.

Expected impact

Minimal short-term price movement expected; potential slight positive bias due to dividend payments.

Evidence & confidence

The announcement confirms dividend payments but does not indicate significant changes in company fundamentals or valuation.

Market effects

Sector

Potential positive sentiment in the financial services sector due to dividend payments.

Regional

Limited regional impact; specific to CareCloud's stock.

Global

Negligible; company-specific news.

Counterpoint

What could challenge this read

Dividend payments are routine and may not significantly influence stock price; focus on broader fundamentals.

Key entities

  • Company
    CareCloud

    A healthcare technology company listed on Nasdaq.

Read at source← All news

Related articles

AUG 13
$CCLDMedAI 8/10

CareCloud (CCLD) Q2 2026 Earnings Call Transcript

CareCloud (CCLD) reported Q2 2026 revenue of $31.9 million, up 16% year over year, mainly from the Medsphere acquisition. GAAP net income was $1.1 million, with breakeven GAAP EPS. Adjusted EBITDA was $5.9 million. The company redeemed $38.2 million of Series B preferred stock using a $50 million credit facility and reaffirmed FY2026 guidance: revenue $128-$132 million and adjusted EBITDA $29-$31 million.

fool.com10 min
AUG 8
Med

CareCloud, Inc. Q2 2026 Earnings Call Summary

CareCloud, Inc. reported 16% Q2 2026 revenue growth, citing Medsphere integration and a shift to recurring technology-enabled solutions at 75% of revenue. The company fully redeemed Series B preferred stock, removing about $3.3M annual dividends, and reaffirmed full-year 2026 guidance. It also acquired Empower Healthcare and Compliance Partners to expand into compliance and audit defense, and set a $60M ATM equity program.

yahoo.com7 min
AUG 6
$CCLDMed

CareCloud, Inc. (CCLD): Results of Operations and Financial Condition

CareCloud, Inc. (CCLD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CareCloud Reports Second Quarter 2026 Results Revenue Grows 16%; Ninth Consecutive Quarter of Positive GAAP Net Income SOMERSET, N.J., August 6, 2026 (GLOBE NEWSWIRE)— CareCloud, Inc. (Nasdaq: CCLD), a leader in AI-powered healthcare technology and revenue cycle mana

SEC EDGAR 8-K4 min
SEP 22
$MMMMed

3M’s CEO Says the Turnaround Is Ahead of Schedule, But PFAS Litigation Keeps Resurfacing

3M (NYSE:MMM) CEO William Brown reported that the company's operational turnaround is ahead of schedule, with improved margins, delivery performance, and new product launches. However, ongoing PFAS litigation, including a recent class action and a lawsuit by the Australian government, presents continued legal risks. 3M expects 20% of sales from new products by 2027 and is tracking above a 25% operating margin by that year.

yahoo.com2 min
SEP 22
$CGCMed

Canopy Growth enters UK medical cannabis market

Canopy Growth (TSE: WEED, NASDAQ: CGC) will supply four medical cannabis strains to the UK market via GROW Group. This expands its international reach, with Europe contributing 12% of its Q2 revenue. Shares trade near 52-week lows. The company reported a narrowed adjusted loss and increased international revenue, driven by Poland. Competitors Aurora and Tilray have entered the UK market through acquisitions.

mugglehead.com2 min